Aandelen in “Medische/verpleegkundige diensten”

Aandeel Datum Koers Evolutie
vlag Value8 31/07 6,700 EUR
-0,74% 		-0,74%
vlag Value8 N.V. - 7% PRF PERPETUAL EUR 1.40 30/07 4,651 EUR
-0,62% 		-0,62%
vlag Verici Dx Plc 30/07 0,300 GBX
-14,29% 		-14,29%
vlag VolitionRX Ltd 31/07 0,718 USD
-10,20% 		-10,20%

Nieuws over “Medische/verpleegkundige diensten”

31/07 · Robbins LLP Notifies Acadia Healthcare (ACHC) Investors that the Lawsuit Survived Defendants' Motion to Dismiss - Contact Robbins LLP for Information · Persbericht

31/07 · Robbins LLP Notifies Acadia Healthcare (ACHC) Investors that the Lawsuit Survived Defendants' Motion to Dismiss - Contact Robbins LLP for Information · Persbericht

30/07 · Castle Biosciences Reports Second Quarter 2026 Results · Persbericht

29/07 · Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients · Persbericht

28/07 · Are FBRX, ACA, BGMS Obtaining Fair Deals for their Shareholders? · Persbericht

22/07 · RAMSAY SANTE : Press Release - Refinancing new steps forward · Persbericht

22/07 · Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference · Persbericht

21/07 · DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call · Persbericht

20/07 · Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy · Persbericht

14/07 · Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test · Persbericht

9/07 · Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026 · Persbericht

6/07 · ENSG INVESTIGATION: Investigation Launched into The Ensign Group, Inc. and Attorneys Encourage Investors and Potential Witnesses to Contact Robbins Geller Rudman & Dowd LLP · Persbericht

1/07 · The Ensign Group (ENSG) Shares Fall Amid Activist Forensic Reports Challenging Patient Care Claims, Legal Compliance -- HBSS · Persbericht

30/06 · $ENSG Notification: Ensign Investigated for Misrepresentations about its Regulatory Issues after 8% Stock Drop · Persbericht

25/06 · DecisionDx®-Melanoma's i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy · Persbericht

25/06 · ENSG Investigation: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm · Persbericht

24/06 · RAMSAY SANTE launches senior debt refinancing · Persbericht

23/06 · Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal · Persbericht

23/06 · ENSG Class Notice: Ensign Investors that Suffered Losses are Notified of the Ongoing Securities Fraud Investigation over Regulatory Issues · Persbericht

19/06 · The Ensign Group (ENSG) Shares Fall Amid Activist Forensic Reports Challenging Patient Care Claims, Legal Compliance -- HBSS · Persbericht

19/06 · Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

Mijn selecties